|
- 2017
Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancerKeywords: Triple negative breast cancer, Obesity, Leptin, Leptin peptide receptor antagonist 2, Iron oxide nanoparticles, Chemotherapy adjuvant Abstract:
|